+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
From
From
From
From
Neurodegenerative Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neurodegenerative Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Canavan Disease Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Canavan Disease Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
From
From
From
From
From
From
Protein Inhibitors Market Report 2026 - Product Thumbnail Image

Protein Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator